一种新型抗精神病药物（FLO 1347）在大鼠、狗和人体中的吸收、消除与代谢（作者译） - Suppr

Suppr

超能文献

[Absorption, elimination and metabolism of a new neuroleptic agent (FLO 1347) in the rat dog and man (author's transl)].

作者信息

Strolin-Benedetti M, Donath A, Frigerio A, Morgan K T, Laville C, Malnoe A

出版信息

Ann Pharm Fr. 1978;36(5-6):279-88.

PMID:30386

Abstract

摘要

相似文献

[Absorption, elimination and metabolism of a new neuroleptic agent (FLO 1347) in the rat dog and man (author's transl)].一种新型抗精神病药物（FLO 1347）在大鼠、狗和人体中的吸收、消除与代谢（作者译）

Ann Pharm Fr. 1978;36(5-6):279-88.

Pharmacokinetics and metabolism of 2-chloro-11-(2-dimethylaminoethoxy)-dibenzo[b,f]thiepine (zotepine) in rat, mouse, dog and man.2-氯-11-（2-二甲基氨基乙氧基）-二苯并[b,f]硫氮杂卓（佐替平）在大鼠、小鼠、犬和人体内的药代动力学与代谢

Arzneimittelforschung. 1979;29(10):1595-600.

Pharmacokinetics and initial distribution of a new neuroleptic agent picobenzide (M-14012-4).一种新型抗精神病药物匹考齐特（M-14012-4）的药代动力学及初始分布

Int J Clin Pharmacol Ther Toxicol. 1985 May;23(5):233-7.

Metabolism of the neuroleptic agent zetidoline in the rat and the dog.

Drug Metab Dispos. 1984 Sep-Oct;12(5):635-40.

[Pharmacokinetic and distribution studies in rats and mice of 14C-brovanexine (author's transl)].14C-溴凡克新在大鼠和小鼠体内的药代动力学及分布研究（作者译）

Arch Farmacol Toxicol. 1978 Aug;4(2):253-60.

[Ambroxol, comparative studies of pharmacokinetics and biotransformation in rat, rabbit, dog and man (author's transl)].氨溴索在大鼠、兔、犬及人体中的药代动力学和生物转化的比较研究（作者译）

Arzneimittelforschung. 1978;28(5a):899-903.

[Pharmacokinetic parameters in relation to structure of the N-pycolyl-3,5-dimethylbenzamides (author's transl)].N-吡啶甲酰基-3,5-二甲基苯甲酰胺的结构与药代动力学参数（作者译）

Arch Farmacol Toxicol. 1977 Aug;3(2):141-56.

[Studies on pharmacokinetics and biotransformation of reproterol in animal and man (author's transl)].间羟异丙肾上腺素在动物及人体中的药代动力学与生物转化研究（作者译）

Arzneimittelforschung. 1977;27(12):37-45.

[Pharmacokinetics of Morocromen in animals and man (author's transl)].[莫罗克孟在动物和人体中的药代动力学（作者译）]

Arzneimittelforschung. 1982;32(5):492-8.

Pharmacokinetic aspects of new antipsychotic drugs.新型抗精神病药物的药代动力学方面

Neuropharmacology. 1981 Dec;20(12B):1299-302.

引用本文的文献

Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride.替必利治疗儿童和青少年抽动障碍的初步治疗参考范围估计。

Eur J Clin Pharmacol. 2021 Feb;77(2):163-170. doi: 10.1007/s00228-020-03000-0. Epub 2020 Sep 28.

Tiapride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation.硫必利。对其药效学和药代动力学特性以及在老年躁动症治疗潜力的综述。

Drugs Aging. 1993 Sep-Oct;3(5):460-78. doi: 10.2165/00002512-199303050-00007.

Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome.硫必利。对其在酒精依赖综合征管理中的药理学及治疗潜力的综述。

Drugs. 1994 Jun;47(6):1010-32. doi: 10.2165/00003495-199447060-00009.

Absorption, metabolism and excretion of 14C-sultopride in the rat.大鼠体内14C-舒必利的吸收、代谢及排泄

Eur J Drug Metab Pharmacokinet. 1984 Jan-Mar;9(1):1-9. doi: 10.1007/BF03189600.

Single oral dose pharmacokinetics of tiapride in patients with Huntington's disease.硫必利在亨廷顿舞蹈症患者中的单次口服剂量药代动力学。

Eur J Clin Pharmacol. 1987;32(6):583-6. doi: 10.1007/BF02455992.

Pharmacokinetics of tiapride in patients with tardive dyskinesia and Huntington's disease.

Eur J Clin Pharmacol. 1986;31(2):191-4. doi: 10.1007/BF00606657.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验